TGF-beta3-null mutation does not abrogate fetal lung maturation in vivo by glucocorticoids
Newborn transforming growth factor (TGF)-beta3-null mutant mice exhibit defects of palatogenesis and pulmonary development. Glucocorticoids, which play a central role in fetal lung maturation, have been postulated to mediate their stimulatory effects on tropoelastin mRNA expression through TGF-beta3 in cultured lung fibroblasts. In the present study, we analyzed the abnormally developed lungs in TGF-beta3-null mutant mice and compared the effects of glucocorticoids on gene expression and lung morphology between TGF-beta3 knockout and wild-type mice. Lungs of TGF-beta3-null mutant mice on embryonic day 18.5 did not form normal saccular structures and had a thick mesenchyme between terminal air spaces. Moreover, the number of surfactant protein C-positive cells was decreased in TGF-beta3-null mutant lungs. Interestingly, glucocorticoids were able to promote lung maturation and increased expression of both tropoelastin and fibronectin but decreased the relative number of surfactant protein C-positive cells in fetal lungs of both genotypes. This finding provides direct evidence that glucocorticoid signaling in the lung can use alternative pathways and can exert its effect without the presence of TGF-beta3.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
1999 |
---|---|
Erschienen: |
1999 |
Enthalten in: |
Zur Gesamtaufnahme - volume:277 |
---|---|
Enthalten in: |
The American journal of physiology - 277(1999), 6 vom: 17. Dez., Seite L1205-13 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Shi, W [VerfasserIn] |
---|
Links: |
---|
Themen: |
7S5I7G3JQL |
---|
Anmerkungen: |
Date Completed 20.01.2000 Date Revised 28.08.2018 published: Print Citation Status MEDLINE |
---|
doi: |
10.1152/ajplung.1999.277.6.L1205 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM105306800 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM105306800 | ||
003 | DE-627 | ||
005 | 20231222134403.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231222s1999 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1152/ajplung.1999.277.6.L1205 |2 doi | |
028 | 5 | 2 | |a pubmed24n0351.xml |
035 | |a (DE-627)NLM105306800 | ||
035 | |a (NLM)10600892 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Shi, W |e verfasserin |4 aut | |
245 | 1 | 0 | |a TGF-beta3-null mutation does not abrogate fetal lung maturation in vivo by glucocorticoids |
264 | 1 | |c 1999 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 20.01.2000 | ||
500 | |a Date Revised 28.08.2018 | ||
500 | |a published: Print | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Newborn transforming growth factor (TGF)-beta3-null mutant mice exhibit defects of palatogenesis and pulmonary development. Glucocorticoids, which play a central role in fetal lung maturation, have been postulated to mediate their stimulatory effects on tropoelastin mRNA expression through TGF-beta3 in cultured lung fibroblasts. In the present study, we analyzed the abnormally developed lungs in TGF-beta3-null mutant mice and compared the effects of glucocorticoids on gene expression and lung morphology between TGF-beta3 knockout and wild-type mice. Lungs of TGF-beta3-null mutant mice on embryonic day 18.5 did not form normal saccular structures and had a thick mesenchyme between terminal air spaces. Moreover, the number of surfactant protein C-positive cells was decreased in TGF-beta3-null mutant lungs. Interestingly, glucocorticoids were able to promote lung maturation and increased expression of both tropoelastin and fibronectin but decreased the relative number of surfactant protein C-positive cells in fetal lungs of both genotypes. This finding provides direct evidence that glucocorticoid signaling in the lung can use alternative pathways and can exert its effect without the presence of TGF-beta3 | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, U.S. Gov't, P.H.S. | |
650 | 7 | |a Fibronectins |2 NLM | |
650 | 7 | |a Glucocorticoids |2 NLM | |
650 | 7 | |a Proteolipids |2 NLM | |
650 | 7 | |a Pulmonary Surfactants |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
650 | 7 | |a Transforming Growth Factor beta |2 NLM | |
650 | 7 | |a Tropoelastin |2 NLM | |
650 | 7 | |a Dexamethasone |2 NLM | |
650 | 7 | |a 7S5I7G3JQL |2 NLM | |
700 | 1 | |a Heisterkamp, N |e verfasserin |4 aut | |
700 | 1 | |a Groffen, J |e verfasserin |4 aut | |
700 | 1 | |a Zhao, J |e verfasserin |4 aut | |
700 | 1 | |a Warburton, D |e verfasserin |4 aut | |
700 | 1 | |a Kaartinen, V |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The American journal of physiology |d 1945 |g 277(1999), 6 vom: 17. Dez., Seite L1205-13 |w (DE-627)NLM000012386 |x 0002-9513 |7 nnns |
773 | 1 | 8 | |g volume:277 |g year:1999 |g number:6 |g day:17 |g month:12 |g pages:L1205-13 |
856 | 4 | 0 | |u http://dx.doi.org/10.1152/ajplung.1999.277.6.L1205 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 277 |j 1999 |e 6 |b 17 |c 12 |h L1205-13 |